Medical Journals

Cathepsin L Activity Controls Adipogenesis and Glucose Tolerance.

Authors:
  • Yang Min
  • Zhang Yaou
  • Pan Jiehong
  • Sun Jiusong
  • Liu Jian
  • Libby Peter
  • Sukhova Galina K
  • Doria Alessandro
  • Katunuma Nobuhiko
  • Peroni Odile D
  • Guerre-Millo Michèle
  • Kahn Barbara B
  • Clement Karine
  • Shi Guo-Ping

From: Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature cell biology

  • Publish Date: Aug 2007
  • ISSN: 1465-7392
  • Volume: 9
  • Issue: 8
  • Pages: 970-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Yang Min, Zhang Yaou, Pan Jiehong, et al. Cathepsin L Activity Controls Adipogenesis and Glucose Tolerance.. Nat. Cell Biol. Aug 2007;9:970-7

Abstract

Cysteine proteases play an important part in human pathobiology. This report shows the participation of cathepsin L (CatL) in adipogenesis and glucose intolerance. In vitro studies demonstrate the role of CatL in the degradation of the matrix protein fibronectin, insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R), essential molecules for adipogenesis and glucose metabolism. CatL inhibition leads to the reduction of human and murine pre-adipocyte adipogenesis or lipid accumulation, protection of fibronectin from degradation, accumulation of IR and IGF-1R beta-subunits, and an increase in glucose uptake. CatL-deficient mice are lean and have reduced levels of serum glucose and insulin but increased levels of muscle IR beta-subunits, fibronectin and glucose transporter (Glut)-4, although food/water intake and energy expenditure of these mice are no less than their wild-type littermates. Importantly, the pharmacological inhibition of CatL also demonstrates reduced body weight gain and serum insulin levels, and increased glucose tolerance, probably due to increased levels of muscle IR beta-subunits, fibronectin and Glut-4 in both diet-induced obese mice and ob/ob mice. Increased levels of CatL in obese and diabetic patients suggest that this protease is a novel target for these metabolic disorders.

Mesh Headings (Keywords): Adipocytes, Adipogenesis, Animals, Body Weight, CCAAT-Enhancer-Binding Protein-alpha, Cathepsins, Cell Differentiation, Cells, Cultured, Cysteine Endopeptidases, Epoxy Compounds, Fibronectins, Glucose, Glucose Intolerance, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Obese, PPAR gamma, Pyridines, Receptor, IGF Type 1, Receptor, Insulin


Check for Full Text / PubMed Unique Identifier (PMID): 17643114


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.